PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. (Q2906826): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in nl: Adding Dutch translations)
(‎Changed label, description and/or aliases in it: Adding Italian translations)
label / itlabel / it
 
PEMDOTLS: Valutazione preclinica dei derivati miltefosine ottimizzati per il trattamento della Leishmaniosi e della Malattia del Sonno.

Revision as of 22:06, 17 January 2022

Project Q2906826 in Portugal
Language Label Description Also known as
English
PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease.
Project Q2906826 in Portugal

    Statements

    0 references
    204,000.0 Euro
    0 references
    240,000.0 Euro
    0 references
    85.0 percent
    0 references
    26 July 2018
    0 references
    25 July 2022
    0 references
    INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
    0 references
    Q2985732 (Deleted Item)
    0 references

    41°8'58.02"N, 8°36'38.84"W
    0 references
    Porto
    0 references

    Identifiers

    POCI-01-0145-FEDER-031013
    0 references